Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success. The post Clinician Adoption: How HealthTech Can Overcome Key Barriers appeared first on MedCity News.
The acquisition has an enterprise value of more than $830 million and will bring to UHS a network of roughly 6,000 licensed therapists.
In a new analysis, the American Medical Association detailed the lack of competition among pharmacy benefit managers and their high level of vertical integration with insurers. The post New AMA Report Highlights Lack of Competition in PBM Market appeared first on MedCity News.
AI hasn’t solved all the problems plaguing healthcare’s revenue cycle — but R1’s Lee Kupferman says that it is getting closer, one gray area at a time. The post What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle? appeared first on MedCity News.
U.S. health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans’ medical records, in a quest to research a link between vaccines and autism — a connection the medical establishment studied for decades and flatly rejects. The Department of Health and Human Services is seeking data from little-known state systems that…
This issue brief reviews the Department of Homeland Security (DHS) proposed rule that would rescind 2022 Biden-era public charge determination regulations. The proposed public charge changes along with other Trump administration policy changes will likely lead to decreased participation in public programs, including Medicaid, among a broad group of immigrant families, including citizen children in…
FibroGen secured regulatory approvals for roxadustat in China and Europe, but the FDA rejected the drug and asked for another clinical trial. By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication. The post AstraZeneca Secures China Rights to Anemia…
Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence form Longitude Health to scale the next generation of capabilities
As more Americans feel the squeeze on their household budgets, paying for healthcare is a growing concern. A 2024 survey by Pew Research Center found that the number of Americans who rate their personal finances positively has dropped from 50% to 40% over the last three years, with nearly 60% of Americans now saying their…
University of Michigan’s Stephanie Taylor, M.D., M.S., describes building trials to test interventions vs. usual care